Benitec Settles Suit Vs. Genscript Over RNAi Patent

Law360, New York (August 24, 2004, 12:00 AM EDT) -- Australian biotech company Benitec Ltd. has settled its U.S. patent infringement case against rival Genscript over gene silencing technologies, just two weeks after it settled its suit against Ambion under similar terms.

As part of the settlement, Genscript has taken from Benitec a worldwide non-exclusive license to make and sell DNA directed RNAi (ddRNAi) based products, Benitec said.

Earlier this month, the Australian biotech company settled with Ambion another defendant in the same law suit. Ambion also agreed to take a non-exclusive license, but financial details...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.